Name Weight

DrugBank
Structure Categories Therapeutic Indication
ID
CAS Number Formula

Abarelix  1416.0630
Anti-Testosterone Agents / For palliative treatment of
DB00106
Antineoplastic Agents advanced prostate cancer.
183552-38-7 C72H95ClN14O14

For the management of the

signs and symptoms of
Abatacept 
92000.0000 moderate-to-severe active
DB01281 Antirheumatic Agents
rheumatoid arthritis, inducing
332348-12-6
major clinical response,
slowing the progr...

Abciximab is indicated as an
adjunct to percutaneous
Abciximab  145651.1000
Anticoagulants / coronary intervention for the
DB00054
Antiplatelet Agents prevention of cardiac ischemic
143653-53-6 C6462H9964N1690O2049S48
complications in patients
undergo...

For treatment of rheumatoid

Adalimumab  144190.3000 Antirheumatic Agents /
arthritis, psoriatic arthritis,
DB00051 Immunomodulatory
ankylosing spondylitis, and
331731-18-1 C6428H9912N1694O1987S46 Agents
Crohn's disease.

Agalsidase beta  45351.6000 For treatment of Fabry's

Enzyme Replacement
DB00103 disease (alpha-galactosidase A
Agents
104138-64-9 C2029H3080N544O587S27 deficiency)

Aldesleukin  15314.8000 For treatment of adults with

DB00041 Antineoplastic Agents metastatic renal cell
85898-30-2 C690H1115N177O202S6 carcinoma.
 As an immunosuppressive
Immunomodulatory
Alefacept  51801.1000 drug, Alefacept can be used
Agents /
DB00092 for treatment of moderate to
Immunosuppressive
222535-22-0 C2306H3594N610O694S26 severe chronic plaque
Agents
psoriasis

Alemtuzumab (Campath) is a
Alemtuzumab  145453.8000 monoclonal antibody therapy
DB00087 Antineoplastic Agents used for treatment of B-cell
216503-57-0 C6468H10066N1732O2005S40 chronic lymphocytic
leukemia.

Alglucerase  55597.4000 For the treatment of Gaucher's

Enzyme Replacement
DB00088 disease (deficiency in
Agents
37228-64-1 C2532H3854N672O711S16 glucocerebrosidase)

Alglucosidase alfa  105270.8020 For the treatment of Pompe

Enzyme Replacement
DB01272 disease (GAA deficiency) in
Agents
420784-05-0 C4758H7262N1274O1369S35 infants and pediatric patients.

Alpha-1-proteinase
44324.5000
inhibitor  Enzyme Replacement For treatment of panacinar
DB00058
Agents emphysema
C2001H3130N514O601S10
9041-92-3

For management of acute

Alteplase  59042.3000
myocardial infarction, acute
DB00009 Thrombolytic Agents
ischemic strok and for lysis of
105857-23-6 C2569H3928N746O781S40
acute pulmonary emboli
 Anakinra  17257.6000 Antirheumatic Agents /
For the treatment of adult
DB00026 Immunomodulatory
rheumatoid arthritis.
143090-92-0 C759H1186N208O232S10 Agents

For lysis of acute pulmonary

Anistreplase  59042.3000
emboli, intracoronary emboli
DB00029 Thrombolytic Agents
and management of
81669-57-0 C2569H3928N746O781S40
myocardial infarction

For the treatment of

264725.5000
Antihemophilic Coagulants / Thrombotic hemophilia A, von Willebrand
DB00025
Factor Agents diseae and Factor XIII
C11794H18314N3220O3553S83
deficiency

Antithymocyte Immunomodulatory For prevention of renal

DB00098
globulin Agents transplant rejection

For prophylactic use to reduce

perioperative blood loss and
Aprotinin  6511.4390
the need for blood transfusion
DB06692 Antifibrinolytic Agents
in patients undergoing
9087-70-1 C284H432N84O79S7
cardiopulmonary bypass in the
cou...

Arcitumomab  144482.5000
Diagnostic Agents /
DB00113 For imaging colorectal tumors
Imaging Agents
154361-48-5 C6398H9900N1714O1995S54
 Asparaginase  31731.9000 For treatment of acute
DB00023 Antineoplastic Agents lympocytic leukemia and non-
9015-68-3 C1377H2208N382O442S17 Hodgkins lymphoma

Immunomodulatory
Basiliximab  143801.3000
Agents / For prophylactic treatment of
DB00074
Immunosuppressive kidney transplant rejection
152923-56-3 C6378H9844N1698O1997S48
Agents

Becaplermin  12294.4000
Anti-Ulcer Agents / For topical treatment of skin
DB00102
Topical ulcers (from diabetes)
165101-51-9 C532H892N162O153S9

As part of combination
Bevacizumab  therapy for metastatic
Antiangiogenesis Agents /
DB00112 colorectal cancer and HER2-
Antineoplastic Agents
216974-75-3 negative metastatic breast
cancer.

Bivalirudin  2180.2853
Anticoagulants / For treatment of heparin-
DB00006
Antithrombotic Agents induced thrombocytopenia
128270-60-0 C98H138N24O33

For the treatment of cervical

Botulinum Toxin Anti-Wrinkle Agents / dystonia in adults to decrease
149322.7000
Type A  Antidystonic Agents / the severity of abnormal head
DB00083
Neuromuscular Blocking position and neck pain
C6760H10447N1743O2010S32
93384-43-1 Agents associated with cervical
dystonia...
 For the treatment of patients
Botulinum Toxin with cervical dystonia to
Type B  150804.0000 reduce the severity of
DB00042 Antidystonic Agents
abnormal head position and
93384-44-2 neck pain associated with
cervical dystonia.

Buserelin 
DB06719
57982-77-1

Investigated for use/treatment

in rheumatoid arthritis,
Canakinumab  145200.0000
juvenile rheumatoid arthritis,
DB06168
inflammatory disorders
914613-48-2 C6452H9958N1722O2010S42
(unspecified), and
autoimmune diseases.

Capromab  For diagnosis of prostate

DB00089 Imaging Agents cancer and detection of intra-
145464-28-4 pelvic metastases.

For the inhibition of premature

Cetrorelix  1491.0900
Infertility Agents / LH surges in women
DB00050
Hormone Antagonists undergoing controlled ovarian
120287-85-6 C72H96ClN17O16
stimulation

For treatment of EGFR-

expressing metastatic
Cetuximab  145781.6000 colorectal cancer in patients
DB00002 Antineoplastic Agents who are refractory to other
205923-56-4 C6484H10042N1732O2023S36 irinotecan-based
chemotherapy regimens.
Cetux...

Name Weight
DrugBank
Structure Categories Therapeutic Indication
ID
CAS Number Formula

Choriogonadotropin
25719.7000
alfa  Fertility Agents / For the treatment of female
DB00097
Gonadotropins infertility
C1105H1770N318O336S26
177073-44-8
 Coagulation Factor
46548.2000
IX  Coagulants / Thrombotic For treatment of hemophilia
DB00100
Agents (Christmas disease).
C2041H3136N558O641S25
9001-28-9

Coagulation factor
45079.1000 For treatment of hemorrhagic
VIIa  Coagulants / Thrombotic
DB00036 complications in hemophilia A
Agents
C1972H3076N560O597S28 and B
9001-25-6

Used to promote debridement

Collagenase  112023.2000 of necrotic tissue in the
Anti-Ulcer Agents /
DB00048 treatment of severe burns and
Topical
9001-12-1 C5028H7666N1300O1564S21 dermal ulcers including
decubitus ulcers.

For use as a diagnostic agent

Corticotropin  4541.0658
in the screening of patients
DB01285 Diagnostic Agents
presumed to have
9002-60-2 C207H308N56O58S
adrenocortical insufficiency.

For use as a diagnostic agent

Cosyntropin  2933.4370
in the screening of patients
DB01284 Diagnostic Agents
presumed to have
16960-16-0 C136H210N40O31S
adrenocortical insufficiency.

Antirheumatic Agents /
Immunomodulatory
Agents / Enzyme
Cyclosporine  1202.6112 For treatment of transplant
Inhibitors / Dermatologic
DB00091 rejection, rheumatoid arthritis,
Agents /
59865-13-3 C62H111N11O12 severe psoriasis
Immunosuppressive
Agents / Antifungal
Agents

Immunomodulatory Zenapax is a humanized

Daclizumab  142612.1000
Agents / monoclonal antibody used for
DB00111
Immunosuppressive prevention of renal transplant
152923-56-3 C6332H9808N1678O1989S42
Agents rejection

For the treatment of

Daptomycin  1620.6706 complicated skin and skin
DB00080 Anti-Bacterial Agents structure infections caused by
103060-53-3 C72H101N17O26 susceptible strains of Gram-
positive microorganisms.
 Darbepoetin alfa  18396.1000 For the treatment of anemia
DB00012 Antianemic Agents (from renal transplants or
11096-26-7 C815H1317N233O241S5 certain HIV treatment)

Defibrotide is used to treat or

prevent a failure of normal
Defibrotide 
blood flow (occlusive venous
DB04932 Antithrombotic Agents
disease, OVD) in the liver of
83712-60-1
patients who have had bone
m...

Denileukin diftitox  57647.3000

For treatment of cutaneous T-
DB00004 Antineoplastic Agents
cell lymphoma
173146-27-5 C2560H4042N678O799S17

Oral formulations may be used

to manage primary nocturnal
Desmopressin  1069.2170 Renal Agents /
enuresis in adults and
DB00035 Hemostatics / Antidiuretic
vasopressin sensitive diabetes
16679-58-6 C46H64N14O12S2 Agents
insipidus, and for control of
tempo...

47301.7000 For treatment of digitoxin

Digoxin Immune
DB00076 Digoxin Antidote overdose or digitalis glycoside
Fab
C2085H3223N553O672S16 toxicity.

Dornase Alfa  29253.9000

Used as adjunct therapy in the
DB00003 Enzyme
treatment of cystic fibrosis.
9003-98-9 C1321H1999N339O396S9

Drotrecogin alfa  55000.0000

For reduction of mortality in
DB00055 Antisepsis Agents
patients with severe sepsis.
60202-16-6 C1786H2779N509O519S29
 For the treatment of adult
Immunomodulatory patients with moderate to
Efalizumab 
Agents / severe chronic plaque
DB00095
Immunosuppressive psoriasis, who are candidates
214745-43-4
Agents for phototherapy or systemic
therapy.

Enfuvirtide is an antiretroviral
Enfuvirtide  4491.8760
Anti-HIV Agents / HIV drug used in combination
DB00109
Fusion Inhibitors therapy for the treatment of
159519-65-0 C204H301N51O64
HIV-1/AIDS.

Epoetin alfa  18396.1000 For treatment of anemia (from

DB00016 Antianemic Agents renal transplants or certain
113427-24-0 C815H1317N233O241S5 HIV treatment)

Anticoagulants /
Eptifibatide  831.9620 For treatment of myocardial
Antiplatelet Agents /
DB00063 infarction and acute coronary
Platelet Aggregation
188627-80-7 C35H49N11O9S2 syndrome.
Inhibitors

For treatment of severe active

rheumatoid arthritis in adults,
Etanercept  51234.9000 Antirheumatic Agents /
severe juvenile idiopathic
DB00005 Immunomodulatory
arthritis, ankylosing
185243-69-0 C2224H3475N621O698S36 Agents
spondylitis, and severe plaque
psor...

Indicated as adjunctive
therapy to improve glycemic
Exenatide  4186.6000
control in patients with Type 2
DB01276
diabetes mellitus who are
141758-74-9 C184H282N50O60S
taking metformin, a
sulfonylurea, or ...

For use as an alternative to

Felypressin  1040.2190
Renal Agents / adrenaline as a localising
DB00093
Vasoconstrictor Agents agent, provided that local
56-59-7 C46H65N13O11S2
ischaemia is not essential.
 Increases leukocyte
Immunomodulatory
Filgrastim  18802.8000 production, for treatment in
Agents / Anti-Infective
DB00099 non-myeloid
Agents / Antineutropenic
143011-72-7 C845H1343N223O243S9 cancer,neutropenia and bone
Agents
marrow transplant

Follitropin beta  22672.9000

For treatment of female
DB00066 Fertility Agents
infertility
9002-68-0 C975H1513N267O304S26

Galsulfase  56000.0000 For the treatment of adults and

Enzyme Replacement
DB01279 children with
Agents
552858-79-4 C2534H3851N691O719S16 Mucopolysaccharidosis VI.

For treatment of CD33-

Gemtuzumab
positive acute myeloid
ozogamicin 
DB00056 Antineoplastic Agents leukemia in patients 60 and
over who are not candidates
220578-59-6
for other chemotherapy.

For reduction of the frequency

Glatiramer Acetate  623.6505 Immunosuppressive
of relapses in patients with
DB05259 Agents / Adjuvants,
Relapsing-Remitting Multiple
147245-92-9 C25H45N5O13 Immunologic
Sclerosis.

Glucagon
3767.1000 For treatment of severe
recombinant 
DB00040 Antihypoglycemic Agents hypoglycemia, also used in
C165H249N49O51S1 gastrointestinal imaging
9007-92-5

Immunomodulatory
Muromonab  146189.7000 For treatment of organ
Agents /
DB00075 transplant recipients,
Immunosuppressive
140608-64-6 C6460H9946N1720O2043S56 prevention of organ rejection
Agents
 Natalizumab 
Immunomodulatory For treatment of multiple
DB00108
Agents sclerosis.
189261-10-7

For the intravenous treatment

of patients with acutely
Nesiritide 
decompensated congestive
DB04899 3464.0000 Cardiac drugs
heart failure who have
124584-08-3
dyspnea at rest or with
minimal activity.

Anabolic Agents /
Octreotide  1019.2390 Hormone Replacement For treatment of acromegaly
DB00104 Agents / Gastrointestinal and reduction of side effects
83150-76-9 C49H66N10O10S2 Agents / Antineoplastic from cancer chemotherapy
Agents, Hormonal

Omalizumab  145058.2000 Anti-Asthmatic Agents /

For treatment of asthma
DB00043 Immunomodulatory
caused by allergies
242138-07-4 C6450H9916N1714O2023S38 Agents

Oprelvekin  19047.2000
Increases reduced platelet
DB00038 Coagulants / Thrombotics
levels due to chemotherapy
145941-26-0 C854H1411N253O235S2

27743.1000
For prophylactic treatment of
DB00045 OspA lipoprotein Vaccines
Lyme Disease
C1198H2012N322O422S2

Oxytocin  1007.1870 Anti-tocolytic Agents / To assist in labor, elective

DB00107 Labor Induction Agents / labor induction, uterine
50-56-6 C43H66N12O12S2 Oxytocics contraction induction

Palifermin  16192.7000 For treatment of oral mucositis

DB00039 Antimucositis Agents associated with chemotherapy
162394-19-6 C721H1142N202O204S9 and radiation therapy.
 Palivizumab  For prophylaxis of respiratory
DB00110 Antiviral Agents diseases casued by respiratory
188039-54-5 syncytial virus.

For treatment of cystic

Pancrelipase  131125.6000
Enzyme Replacement fibrosis, chronic
DB00085
Agents pancreatitis,and pancreatic
53608-75-6 C5850H8902N1606O1739S49
duct blockage

For the treatment of EGFR-

expressing, metastatic
Panitumumab  colorectal carcinoma that is
DB01269 Antineoplastic Agents refractory to
339177-26-3 fluoropyrimidine-,
oxaliplatin-, and irinotecan-
contai...

Pegademase bovine  40788.2000

Enzyme Replacement For treatment of adenosine
DB00061
Agents deaminase deficiency
9026-93-1 C1821H2834N484O552S14

Pegaptanib  For the treatment of

DB04895 50000.0000 neovascular (wet) age-related
222716-86-1 macular degeneration.

Pegaspargase 31731.9000
For treatment of acute
DB00059 Antineoplastic Agents
lymphoblastic leukemia
130167-69-0 C1377H2208N382O442S17

Increases leukocyte
Anti-Infective Agents /
Pegfilgrastim  18802.8000 production, for treatment in
Antineutropenic Agents /
DB00019 non-myeloid cancer,
Immunomodulatory
208265-92-3 C845H1343N223O243S9 neutropenia and bone marrow
Agents
transplant
 Peginterferon alfa- Antineoplastic Agents / For treatment of hairy cell
2a  Antiviral Agents / leukemia, malignant
DB00008 60000.0000
Immunomodulatory melanoma, and AIDS-related
198153-51-4 Agents Kaposi's sarcoma.

For the treatment of chronic

Peginterferon alfa- Antineoplastic Agents / hepatitis C in patients not
2b  Antiviral Agents / previously treated with
DB00022 31000.0000
Immunomodulatory interferon alpha who have
99210-65-8 Agents compensated liver disease and
are at lea...

Pegvisomant is a growth
Pegvisomant  22129.0000 Anabolic Agents /
hormone receptor antagonist
DB00082 Hormone Replacement
used for the treatment of
218620-50-9 C990H1532N262O300S7 Agents
acromegaly.

For the treatment of type 1 and

Pramlintide  3949.3896 type 2 diabetes mellitus as an
DB01278 adjunct to preprandial insulin
151126-32-8 C171H267N51O53S2 therapy in patients without
adequate glycemic control...

Ranibizumab  48349.6110 For the treatment of patients

DB01270 with neovascular (wet) age-
347396-82-1 C2158H3282N562O681S12 related macular degeneration.

For treatment of
Rasburicase  34109.5000
hyperuricemia, reduces
DB00049 Antihyperuricemic Agents
elevated plasma uric acid
134774-45-1 C1521H2381N417O461S7
levels (from chemotherapy)

For lysis of acute pulmonary

Reteplase  39589.6000
emboli, intracoronary emboli
DB00015 Thrombolytic Agents
and management of
133652-38-7 C1736H2671N499O522S22
myocardial infarction
 For treatment of CD20-
Rituximab  143859.7000 positive non-Hodgkins
DB00073 Antineoplastic Agents lymphoma, chronic
174722-31-7 C6416H9874N1688O1987S44 lymphocytic leukemia, and
rheumatoid arthritis.

Antiosteporotic Agents /
Salmon Calcitonin  3431.8530
Antihypocalcemic For the treatment of post-
DB00017
Agents / Bone Density menopausal osteoporosis
47931-85-1 C145H240N44O48S2
Conservation Agents

Immunomodulatory
Sargramostim  14434.5000
Agents / Antineoplastic For the treatment of cancer
DB00020
Agents / Anti-Infective and bone marrow transplant
83869-56-1 C639H1006N168O196S8
Agents

Satumomab
141478.9000
Pendetide  For diagnosis of extrahepatic
DB00057 Imaging Agents
malignant cancers
C6268H9708N1666O1971S48
138955-26-7

3056.4000 For diagnosis of pancreatic

DB00021 Secretin Diagnostic Agents exocrine dysfunction and
C130H219N43O42 gastrinoma

Sermorelin  3357.8820 Anabolic Agents / For the treatment of dwarfism,

DB00010 Hormone Replacement prevention of HIV-induced
86168-78-7 C149H246N44O42S Agents weight loss

Serum albumin  66472.2000 For treatment of severe blood

DB00096 Serum substitutes loss, hypervolemia,
9048-49-1 C2936H4624N786O889S41 hypoproteinemia.

Goserelin  1269.4105 Antineoplastic Agents /

Breast cancer; Prostate
DB00014 Antineoplastic Agents,
carcinoma; Endometriosis
65807-02-5 C59H84N18O14 Hormonal
 Human Serum
66472.2000 For treatment of severe blood
Albumin 
DB00062 Serum substitutes loss, hypervolemia,
C2936H4624N786O889S41 hypoproteinemia
9048-49-1

Hyaluronidase  53870.9000 For increase of absorption and

Anesthetic Adjuvants /
DB00070 distribution of other injected
Permeabilizing Agents
488712-31-8 C2455H3775N617O704S21 drugs and for rehydration.

Ibritumomab  143375.5000
For treatment of non-
DB00078 Antineoplastic Agents
Hodgkin's lymphoma
174722-31-7 C6382H9830N1672O1979S54

Idursulfase  76000.0000 For the treatment of Hunter

Enzyme Replacement
DB01271 syndrome in adults and
Agents
50936-59-9 C2654H4000N688O774S14 children ages 5 and older.

Imiglucerase  55597.4000 For the treatment of Gaucher's

Enzyme Replacement
DB00053 disease (deficiency in
Agents
143003-46-7 C2532H3854N672O711S16 glucocerebrosidase)

To manage the signs and

Immunomodulatory symptoms, as well as to
Infliximab  144190.3000
Agents / induce and maintain clinical
DB00065
Immunosuppressive remission in adults with
170277-31-3 C6428H9912N1694O1987S46
Agents moderate to severe active
Crohn's disease or ...

For the treatment of type 1 or

Insulin Detemir  2 diabetes mellitus. May be
Hypoglycemic Agents /
DB01307 used in combination with oral
Antidiabetic
169148-63-4 C267H402N64O76S6 anti-diabetic agents in type 2
diabetic patients who are n...
 For the treatment of Type 1 or
Insulin Glargine 6063.0000 2 diabetes mellitus in patients
Hypoglycemic Agents /
DB00047 over 17 years old who require
Antidiabetic
160337-95-1 C267H408N72O77S6 a long-acting (basal) insulin
for the control of hyper...

For the treatment of Type 1

and 2 diabetes mellitus.
Insulin Glulisine 
Hypoglycemic Agents / Should be used in regimens
DB01309
Antidiabetic including a long-acting or
207748-29-6 C258H384N64O78S6
basal insulin analogue unless
it is used...

For the treatment of Type 1 or

2 diabetes mellitus. To be used
Insulin Lispro  5808.0000
Hypoglycemic Agents / in conjunction with an
DB00046
Antidiabetic intermediate or long-acting
133107-64-9 C257H387N65O76S6
insulin except when used in a
con...

Insulin recombinant  5795.6000

For treatment of Type I and II
DB00030 Hypoglycemic Agents
diabetes mellitus.
9004-10-8 C257H387N65O76S6

Insulin, porcine 5795.6000

For the treatment of type I and
DB00071 Hypoglycemic Agents
II diabetes mellitus.
9004-14-2 C257H387N65O76S6

For the treatment of chronic

Interferon Alfa-2a, hepatitis C, hairy cell
19241.1000
Recombinant  Antineoplastic Agents / leukemia, AIDS-related
DB00034
Antiviral Agents Kaposi's sarcoma, and chronic
C860H1353N227O255S9
77907-69-8 myelogenous leukemia. Also
for the treatm...
 Interferon Alfa-2b, For the treatment of hairy cell
19271.0000 Antineoplastic Agents /
Recombinant  leukemia, malignant
DB00105 Immunomodulatory
melanoma, and AIDS-related
C860H1353N229O255S9 Agents / Antiviral Agents
99210-65-8 Kaposi's sarcoma.

Interferon alfa-n1  19241.1000 For treatment of venereal or

Immunomodulatory
DB00011 genital warts caused by the
Agents / Antiviral Agents
74899-72-2 C860H1353N227O255S9 Human Papiloma Virus

For the intralesional treatment

Antineoplastic Agents /
of refractory or recurring
DB00018 Interferon alfa-n3 Immunomodulatory
external condylomata
Agents / Antiviral Agents
acuminata.

For the treatment of hairy cell

Interferon alfacon-1  19343.0000 Antineoplastic Agents /
leukemia, malignant
DB00069 Immunomodulatory
melanoma, and AIDS-related
118390-30-0 C860H1353N227O255S9 Agents / Antiviral Agents
Kaposi's sarcoma

For treatment of
Interferon beta-1a  20027.0000
Immunomodulatory relapsing/remitting multiple
DB00060
Agents / Antiviral Agents sclerosis, also for condyloma
145258-61-3 C908H1408N246O252S7
acuminatum

Interferon beta-1b is a drug

used for the treatment of
Interferon beta-1b  20011.0000
Immunomodulatory relapsing/remitting multiple
DB00068
Agents / Antiviral Agents sclerosis. It has been shown to
145155-23-3 C908H1408N246O253S6
slow the advance of the
disease...
 Interferon gamma- Interferon gamma-1b is used
17145.6000
1b  Immunomodulatory for the treatment of Chronic
DB00033
Agents / Antiviral Agents granulomatous disease and
C761H1206N214O225S6
82115-62-6 Osteopetrosis.

IVIg is used in the treatment

Intravenous of immunodeficiencies, as
142682.3000
Immunoglobulin Immunomodulatory well as autoimmune and
DB00028
Agents / Anti-Infectives inflammatory disorders. These
C6332H9826N1692O1980S42
9007-83-4 indications includes idiopathic
thromb...

Laronidase  69899.4000
Enzyme Replacement For the treatment of
DB00090
Agents mucopolysaccharidosis
210589-09-6 C3160H4848N898O881S12

Lepirudin  6963.4250 Anticoagulants /

For the treatment of heparin-
DB00001 Antithrombotic Agents /
induced thrombocytopenia
120993-53-5 C287H440N80O110S6 Fibrinolytic Agents

For treatment of prostate

Leuprolide  1209.3983
Antineoplastic Agents / cancer, endometriosis, uterine
DB00007
Anti-Estrogen Agents fibroids and premature
53714-56-0 C59H84N16O12
puberty

Lutropin alfa  23390.3000

For treatment of female
DB00044 Fertility Agents
infertility
152923-57-4 C1014H1609N287O294S27

For the long-term treatment of

growth failure in pediatric
Mecasermin  7649.0000
patients with Primary IGFD or
DB01277
with GH gene deletion who
68562-41-4 C331H518N94O101S7
have developed neutralizing
anti...

Menotropins  23390.3000
For the treatment of female
DB00032 Fertility Agents
infertility
61489-71-2 C1014H1609N287O294S27
 Serum albumin
66472.2000
iodonated  For determination of total
DB00064 Imaging Agents
blood and plasma volumes
C2936H4624N786O889S41
9048-49-1

Somatropin
22129.0000 Anabolic Agents / For treatment of dwarfism,
recombinant 
DB00052 Hormone Replacement acromegaly and prevention of
C990H1532N262O300S7 Agents HIV-induced weight loss
12629-01-5

For the treatment of acute

evolving transmural
Streptokinase 47286.7000
myocardial infarction,
DB00086 Thrombolytic Agents
pulmonary embolism, deep
9002-01-1 C2100H3278N566O669S4
vein thrombosis, arterial
thrombosis or emolism and ...

Teicoplanin  1879.6580 Antibacterial Agents / For the treatment of bacterial

DB06149 Glycopeptide infections caused by
61036-62-2 C88H97Cl2N9O33 antibacterials susceptible microorganisms.

Tenecteplase 58951.2000 For treatment of myocardial

DB00031 Thrombolytic Agents infarction and lysis of
191588-94-0 C2561H3919N747O781S40 intracoronary emboli

For the treatment of

osteoporosis in men and
Teriparatide  4117.7150
Bone Density postmenopausal women who
DB06285
Conservation Agents are at high risk for having a
52232-67-4 C181H291N55O51S2
fracture. Also used to increase
bone mass in me...

Indicated as an adjuvant for

Immunomodulatory
Thymalfasin  3108.2755 influenza vaccine in elderly
Agents / Adjuvants,
DB04900 patients and as an adjuvant for
Immunologic /
62304-98-7 C129H215N33O55 both influenza and hepatitis B
Antineoplastic Agents
vaccines in chronic hemodi...
 Thyrotropin Alfa  22672.9000
For detection of residueal or
DB00024 Diagnostic Agents
recurrent thyroid cancer
9002-71-5 C975H1513N267O304S26

Tositumomab  143859.7000 For treatment of non-

DB00081 Antineoplastic Agents Hodgkin's lymphoma (CD20
192391-48-3 C6416H9874N1688O1987S44 positive, follicular)

For treatment of early stage

Trastuzumab  145531.5000 HER2-positive breast cancer,
DB00072 Antineoplastic Agents or metastatic breast cancer that
180288-69-1 C6470H10012N1726O2013S42 substantially overexpress
HER2.

Urofollitropin  980.1620
For treatment of female
DB00094 Fertility Agents
infertility
146479-72-3 C42H65N11O12S2

Urokinase can be used for the

treatment of pulminary
Urokinase  31126.5000
embolism, coronary artery
DB00013 Thrombolytic Agents
thrombosis, IV catheter
9039-53-6 C1376H2145N383O406S18
clearance, and venous and
arterial blood clots.

For the treatment of enuresis,

Vasopressin  1050.2150 Antidiuretics /
polyuria, diabetes insipidus,
DB00067 Vasoconstrictor Agents /
polydipsia and oesophageal
11000-17-2 C43H67N15O12S2 Oxytocics
varices with bleeding